164 filings
Page 7 of 9
6-K
eszleqk31 2wbqwkwbg
24 Feb 17
Trillium Therapeutics Provides Additional Details on Asco- Sitc Conference Presentation on TTI-621
12:00am
6-K
0r5iwpqoi9bh883i
15 Feb 17
Trillium Therapeutics to Present New Data from TTI-621 Phase 1 Trial
12:00am
6-K
p8zy0v
7 Feb 17
Form 51-102F3 Material Change Report
12:00am
6-K
9g7kxss
2 Feb 17
Trillium Therapeutics Outlines Anticipated Activities and Milestones for 2017
12:00am
6-K
7ubkcbebawmhtf
31 Jan 17
Current report (foreign)
12:00am
6-K
ng1o430pjz5fy9i23iq
6 Jan 17
Current report (foreign)
12:00am
6-K
p4lxfacr4
5 Dec 16
Current report (foreign)
12:00am
6-K
ht89m4szm
29 Nov 16
Current report (foreign)
12:00am
6-K
vqehmn4 xwn
10 Nov 16
Current report (foreign)
12:00am
6-K
piudvf0fvj3r 24pp
3 Nov 16
Trillium Therapeutics Announces Investor and Scientific Presentation Schedule for Remainder of 2016
12:00am
6-K
oi2a1
2 Nov 16
Current report (foreign)
12:00am
6-K
f9x lr7ydpb6w
31 Aug 16
Current report (foreign)
12:00am
6-K
jh6cd cirjjc1z
23 Aug 16
Current report (foreign)
12:00am
6-K
l8bs812r
17 Aug 16
Trillium Therapeutics Receives Fda Clearance to Proceed with TTI-621 In Clinical Trial Targeting Solid Tumors and Mycosis Fungoides
12:00am
6-K
h5wja240 83a9ox
12 Aug 16
Current report (foreign)
12:00am
6-K
tl4f2xe
7 Jun 16
Current report (foreign)
12:00am
6-K
qoca2j wdk9clctue
31 May 16
Trillium Announces Voting Results from the Annual and Special Meeting of Shareholders
12:00am
6-K
svs0661 f5yh
18 May 16
Current report (foreign)
12:00am
6-K
e36f4s6upu4t0
13 May 16
Interim Condensed Consolidated Financial Statements
12:00am
6-K
v9e6lxzwfd0d ym
21 Apr 16
Current report (foreign)
12:00am